Well all us shareholders are now OTAT dependent. That is where the log jam exists. Next 6 months it will be all about Covid Ards really. No matter what they do with vaccines, doctors need to have our treatment to save lives. If the management team are to be believed, we can satisfy the OTAT requirements. A trial design has I expect already been formulated and there will be no shortage of patients. It will not be a long trial. There will be a requirement I expect for additional funding but not necessarily a capital raise. But the Covid market is huge and here to stay.
For me the poignant fact was the success of SRGvHD sales in Japan signifying more lives saved. How tragic it was only in Japan.
it’s nearly 1.30am here and I’m up at 5. Today’s takeaways for me, is the pathway of about 365 sleeps till retirement. I can cope with that.
regards
Yelrom
Ann: MSB Annual Financial Results and Operational Progress, page-50
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |